Drugmaker GSK sees sales rise thanks to new products

Drugmaker GlaxoSmithKline says third-quarter sales rose 4 percent, driven by new products such as the company's Tivicay HIV treatment and Ellipta respiratory therapy. Sales increased to 7.84 billion pounds from 7.55 billion pounds in the same period last year.

from Biotech News